Novartis | NVS - Devedores Comerciais

Preço das Ações
146.03
Mudança Diária
-2.13 -1.44%
Mensal
-11.34%
Anual
30.22%
Q1 Previsão
142.44




Devedores Comerciais Alterar Data
AbbVie USD 12.77B 132M 2025-09
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Bausch Health Companies USD 2.35B 66M 2025-12
Biogen USD 1.85B 234M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Canopy Growth CAD 140.42M 113.56M 2025-12
Corcept Therapeutics USD 59.79M 9.84M 2025-12
Drreddys Laboratories INR 1.41B 11.6M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Glaxosmithkline GBP 10.45B 707.81M 2025-12
J&J USD 17.61B 235M 2025-09
Merck USD 12.12B 596M 2025-09
Novartis USD 12.29B 3.3B 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 190.46M 8.54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 397M 100M 2025-12
Sanofi EUR 397M 186.13M 2025-12
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
Zoetis USD 1.59B 49M 2025-12